Ease: Empagliflozin Beneficial In Type 1 Diabetes Dka A Risk | Latest News RSS feed

Ease: Empagliflozin Beneficial In Type 1 Diabetes Dka A Risk - Latest News


Boehringer Ingelheim and Lilly present full results from EASE Phase III program for empagliflozin as adjunct to insulin in type 1 diabetes

The EASE program results were published online ... Canada. "Given the risk of diabetic ketoacidosis for people with type 1 diabetes, the 2.5 mg empagliflozin dose warrants consideration, as it balance... read more

US FDA approves sNDA to add trial data in labels of three type 2 diabetes drugs within empagliflozin family

The data show that empagliflozin ... for the treatment of type 1 diabetes or diabetic ketoacidosis. Glyxambi has not been studied in patients with a history of pancreatitis, and it is unknown if using ... read more

Lexicon Likely Looking At Even More Competition In Type 1 Diabetes

Lexicon could really use some good news, as the company ... s somewhat cryptic release regarding its EASE-2 and EASE-3 trials of Jardiance in Type 1 diabetes back in the summer created some hope that ... read more

Looking for another news?


Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes

The number of adjudicated diabetic ketoacidosis events was comparable between empagliflozin 2.5 mg and placebo and higher than placebo in adults with type 1 diabetes on empagliflozin 10 mg and 25 mg. ... read more


Tyler Junior College nursing student uses personal setbacks as motivation to work harder toward graduation

Hargrove suggested that she would be a good nurse ... not return for the spring semester. Having Type 1 diabetes put Thomas' pregnancy at high risk. Despite watching her diet and blood sugar ... read more

What to Know About the Flu if You Have Diabetes

People with diabetes (Type 1, Type 2 or gestational), even when well-managed, are at high risk ... DKA can cause a coma or even death. Even when you are feeling at your worst it is important to stay v... read more

Heart meeting features fish oil, vitamin D, cholesterol news

A drug not only helped people with diabetes control blood sugar and lose weight, but also lowered their risk of needing hospitalization for heart failure. Good news for everyone ... of the arteries, t... read more

A Weak Xermelo Ramp Continues To Weigh On Lexicon

If Neurocrine’s (NBIX) launch of Ingrezza in tardive dyskinesia is a good example of an ... non-insulin therapy option for Type 1 diabetes. Data also continue to show that these drugs do increase the ... read more

Boehringer Ingelheim and Lilly present full results from EASE Phase III programme for empagliflozin as adjunct to insulin in type 1 diabetes

The EASE programme results were published online ... Canada. “Given the risk of DKA for people with type 1 diabetes, the 2.5 mg empagliflozin dose warrants consideration, as it balances glycaemic and ... read more

Boehringer Ingelheim and Lilly expand heart failure programme for empagliflozin with new exercise capacity trials

We look forward to seeing whether empagliflozin can help address this unmet need.” “In the EMPA-REG OUTCOME ® trial, it was encouraging to see a significant reduction in the risk ... with type 1 diabe... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us